ABVX logo

ABIVAX SA (ABVX) Company Overview

Profile

Full Name:

ABIVAX Société Anonyme

Sector:

Healthcare

Industry:

Biotechnology

Country:

France

IPO:

October 20, 2023

Indexes:

Not included

Description:

Abivax SA focuses on developing innovative therapies for inflammatory diseases and viral infections. The company’s lead candidate, ABX464, targets ulcerative colitis and HIV, aiming to improve patient outcomes through unique mechanisms of action. Abivax is committed to advancing its clinical programs and expanding treatment options.

Events Calendar

Earnings

Next earnings date:

Mar 24, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Apr 2, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 10, 25 JMP Securities
Market Outperform
Dec 4, 24 JMP Securities
Market Outperform
Jul 29, 24 Laidlaw & Co.
Buy
May 20, 24 BTIG
Buy
Apr 29, 24 Piper Sandler
Overweight
Apr 29, 24 Guggenheim
Buy
Apr 11, 24 Morgan Stanley
Equal-Weight
Nov 14, 23 Morgan Stanley
Equal-Weight
Nov 14, 23 Leerink Partners
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for ABIVAX SA?
  • Does ABIVAX SA pay dividends?
  • What sector is ABIVAX SA in?
  • What industry is ABIVAX SA in?
  • What country is ABIVAX SA based in?
  • When did ABIVAX SA go public?
  • Is ABIVAX SA in the S&P 500?
  • Is ABIVAX SA in the NASDAQ 100?
  • Is ABIVAX SA in the Dow Jones?
  • When was ABIVAX SA's last earnings report?
  • When does ABIVAX SA report earnings?

What is the ticker symbol for ABIVAX SA?

The ticker symbol for ABIVAX SA is NASDAQ:ABVX

Does ABIVAX SA pay dividends?

No, ABIVAX SA does not pay dividends

What sector is ABIVAX SA in?

ABIVAX SA is in the Healthcare sector

What industry is ABIVAX SA in?

ABIVAX SA is in the Biotechnology industry

What country is ABIVAX SA based in?

ABIVAX SA is headquartered in France

When did ABIVAX SA go public?

ABIVAX SA's initial public offering (IPO) was on October 20, 2023

Is ABIVAX SA in the S&P 500?

No, ABIVAX SA is not included in the S&P 500 index

Is ABIVAX SA in the NASDAQ 100?

No, ABIVAX SA is not included in the NASDAQ 100 index

Is ABIVAX SA in the Dow Jones?

No, ABIVAX SA is not included in the Dow Jones index

When was ABIVAX SA's last earnings report?

ABIVAX SA's most recent earnings report was on Nov 7, 2024

When does ABIVAX SA report earnings?

The next expected earnings date for ABIVAX SA is Mar 24, 2025